Financials

News Discussions Technicals Forecast Seasonals Options

BCAX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Bicara Therapeutics Inc. operating, investing, and financing activities

BCAX free cash flow for Q1 25 is -28.11 M USD. For 2024, BCAX free cash flow was -74.82 M USD and operating cash flow was -74.75 M USD.

Q3 '23

Q1 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '23

Q1 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—